Pharmaceuticals, Biotechnology and Life Sciences
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…
SARASOTA, Fla., March 18, 2025 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for…
Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets Cytek Muse Micro The Cytek® Muse® Micro is an…
Doubled the royalty and milestone portfolio to over 120 royalty assets with significant milestone potential through five transactions in 2024…
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today…
FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial…
Conference call and webcast scheduled for March 18, 2025, at 8:30 A.M. EDT / 1:30 P.M. CETPARIS and CAMBRIDGE, Mass.,…
Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025 Commercial launch in the PRC of…
– Continued favorable safety profile for DYNE-251 – – DELIVER Registrational Expansion Cohort is fully enrolled; data from this cohort planned…
– The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα…